Foundation Medicine at ASH 2018
Posters and Presentations
SATURDAY, DECEMBER 1
Poster Presentation 1561 | Session 621
6:15pm – 8:15pm | Hall GH, San Diego Convention Center
Sally Trabucco, Presenter, Foundation Medicine

SUNDAY, DECEMBER 2


Oral Presentation 287 | Session 615
Enasidenib is Highly Active in Previously Untreated IDH2 Mutant AML: Early Results from the Beat AML Master Trial
7:30am – 9:00am | Seaport Ballroom F, Manchester Grand Hyatt San Diego
Jo-Anne Vergilio, Contributor, Foundation Medicine
 
Poster Presentation 2773 | Session 617
6:00pm – 8:00pm | Hall GH, San Diego Convention Center
Dean Pavlick, Presenter, Foundation Medicine
Lee Albacker, Contributor, Foundation Medicine
MONDAY, DECEMBER 3
Oral Presentation 559 | Session 616
Initial Report of the BeatAML Umbrella Study for Newly Diagnosed AML: Evidence of Feasibility and Early Success in Molecularly Driven Phase 1 and 2 Studies
7:30am – 8:30am | Seaport Ballroom F, Manchester Grand Hyatt San Diego
Jo-Anne Vergilio, Contributor, Foundation Medicine
 
Poster Presentation 4053 | Session 616
Phase 1b Dose Escalation Study of BI 836858 and Azacytidine in Previously Untreated AML: Results from Beat AML S2
6:00pm – 8:00pm | Hall GH, San Diego Convention Center
Jo-Anne Vergilio, Contributor, Foundation Medicine
light gray divider.png

To learn more about FoundationOne Heme, our comprehensive genomic profiling test designed specifically for patients with hematologic malignancies, please visit our website.  FoundationOne Heme is validated to detect the four main classes of genomic alterations in more than 400-cancer related genes as well as known, novel, and complex fusions.

FOUNDATIONONE HEME

Our recent publication, 'Genomic Landscape of Adult and Pediatric BCRABL1-Like B Lymphoblastic Leukemia Using Parallel DNA and RNA Sequencing' documents the importance of comprehensive genomic profiling for your B-ALL patients. 

VIEW PUBLICATION

 

Contact Us

If you are interested in connecting with one of our biopharma professionals to discuss partnership opportunities, please contact biopharma@foundationmedicine.com. You can also learn more about our biopharma partnerships by visiting our website.

 

Sign up for email updates from Foundation Medicine below, including the option to download a case study describing how we can help with clinical trial enrollment.